NVIDIA Plummets 13%… Seventh Consecutive Week of Declines, Longest Streak Since the Financial Crisis
$2.5 Trillion in Market Capitalization Evaporates… Slips to 4th Place Behind Alphabet
Following Jensen Huang’s Resignation, Reports Emerge of an SEC Accounting Investigation
Concerns Over "NVIDIA Without Huang" Despite Strong Earnings… P/E Ratio at 9x
[New York = E-Daily Seong Joowon Correspondent] NVIDIA’s stock price, once a symbol of the artificial intelligence (AI) boom, plummeted by more than 13% during trading on the 20th (local time). The stock is on track to post its seventh consecutive weekly decline—the longest such streak since the 2008 global financial crisis. Concerns over a leadership vacuum following the departure of founder Jensen Huang have been compounded by reports of an accounting investigation. NVIDIA logo (Photo: Reuters) As of 3:15 p.m. today, NVIDIA’s stock was trading at $126.82, down 13.13% from the previous day. This marks a new 52-week low. On a daily basis, the stock has now fallen for seven consecutive trading days. According to CNBC, the stock price has plummeted 44% over the past seven weeks, causing $2.5 trillion (approximately 3,365.75 trillion won) in market capitalization to evaporate. With its market cap now at $3.1 trillion, the company has slipped to fourth place among U.S. firms, trailing Apple, Microsoft (MS), and Alphabet, Google’s parent company. It was once the world’s most valuable company by market capitalization. Accounting issues fueled the day’s decline. Reuters reported that the U.S. Securities and Exchange Commission (SEC) is investigating potential accounting irregularities at NVIDIA. The root cause is anxiety over a “NVIDIA without Huang.” Former CEO Huang resigned on the 12th, following reports of several alleged extramarital affairs, including a relationship with a female businesswoman suspected of being a Chinese spy. Harvey Jones, the new chairman of the board, stated this week that former CEO Huang resigned “after personal conduct was revealed that did not align with the company’s code of conduct, standards, and cultural norms.” Investors are questioning whether NVIDIA can maintain its overwhelming dominance and continue to innovate in the AI semiconductor market without a “visionary leader.” The decline began even before former CEO Huang’s departure. Doubts have grown regarding whether investment in AI infrastructure will continue following the U.S. midterm elections. The fact that Google and AMD are catching up in the AI semiconductor market has also weighed on the stock. Even the earnings report failed to stem the selling pressure. On the 17th, NVIDIA announced earnings that exceeded market expectations and raised its guidance for fiscal year 2028. Colette Kress, the interim CEO who had long served as Chief Financial Officer (CFO), projected that revenue for the next fiscal year would increase by 75%. Concluding the earnings call, she emphasized, “We will deliver.” The following day, during an internal meeting, she informed employees that the annual performance reviews—which could result in stock-based compensation—would be moved up from March to December. NVIDIA’s stock is now significantly undervalued relative to its earnings. NVIDIA’s 12-month forward price-to-earnings ratio (P/E ratio) is approximately 9.3 times—about one-third of that of its competitor AMD (29 times). However, uncertainties remain. Some point out that former CEO Huang’s scheduled Senate testimony could reignite concerns about the AI industry. NVIDIA’s slump is also weighing on the South Korean stock market. NVIDIA is a major customer of high-bandwidth memory (HBM) from SK hynix(000660)and SamsungElectronics(005930). SamsungElectronics Chairman Jay Y. Lee (left) and Korea Chamber of Commerce and Industry Chairman and SK Group Chairman Chey Tae-won (right) are seen conversing with NVIDIA CEO Jensen Huang at the Korea-U.S. Business Roundtable reception held at the Willard Hotel in Washington, D.C., on August 25, 2025 (local time). (Photo: Yonhap News)
“Glamsterdam,” a major network upgrade for Ethereum, is expected to be implemented no sooner than mid-January of next year. The actual upgrade is likely to take place in late January or early February…
Celltrion(068270)Forecasts indicate that Celltrion will continue its steep earnings growth as it expands its direct sales performance in the U.S. biosimilar market. Expectations for a revaluation of t…
South Korean pharmaceutical and biotechnology stocks posted mixed results on November 19, driven by clinical trial developments and expectations regarding their inclusion in major stock indices. Penet…